FLGT · NASDAQ · Medical - Diagnostics & Research

Fulgent Genetics (FLGT)

Combines hereditary-cancer and pathology testing with a nanoencapsulated cancer-drug pipeline in clinical trials.

$21.65
After hours+0.01 (+0.05%)
At close$21.64(+0.46%)